Navigation Links
DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing
Date:10/2/2008

- Dr. Robert Weiss, Director of Maryland Laser, Skin and Vein Institute, Introduces DOT Therapy to his practice -

BALTIMORE, Oct. 2 /PRNewswire/ -- Robert Weiss, M.D., board certified dermatologist, is among the first physicians in the U.S. to offer his patients DOT Therapy (Dermal Optical Thermolysis), the latest, state-of-the-art procedure in laser skin resurfacing. Dr. Weiss is an internationally renowned dermatologist, who is in private practice in Hunt Valley, Md. and is also Director, Maryland Laser, Skin and Vein Institute.

According to Dr. Weiss, "DOT Therapy is a highly effective tool for reversing signs of aging of the skin. The key is in the way the engineers have designed the laser application for the skin. And, skin numbing cream is all that is needed."

DOT Therapy has taken laser skin rejuvenation to a whole new level.

-- This new procedure precisely delivers CO2 laser energy targeting the

face, neck, decolletage, hand and arms, opening up whole new areas for

laser rejuvenation.

-- DOT Therapy effectively improves sun damage, brown spots, wrinkles, fine

lines, and acne scarring with little downtime or discomfort -- usually

in minutes.

-- Patients are pleased with the face and body skin tightening and

improvement of crepe skin.

-- The SmartXide DOT laser system has the unique capability to deliver a

customized pattern of tiny, micro-sized dots, rather than treating the

entire skin surface, so healing is fast.

DOT Therapy has been introduced through an alliance between Eclipsemed, Ltd., one of the country's leading aesthetic laser distributors, and DEKA, one of the world's largest laser manufacturers. The SmartXide DOT system is an advanced CO2 (carbon dioxide) laser. The CO2 laser is the most common type of laser used for skin resurfacing: thoroughly proven and tested. CO2 lasers of the past covered the entire surface of the skin, resulting in a significant amount of downtime to heal, discomfort for the patient and prolonged redness of the skin. In addition, the old CO2 lasers could not treat non-facial areas like the neck and decolletage easily because skin in these areas did not heal as well as the face. DOT Therapy has received clearance from the Food & Drug Administration.

For more information, please visit http://www.dottherapy.com or http://www.eclipsemed.com.

Press Contact: Wendy Maurice, wendy@trentandcompany.com

Marketing Contact: Michelle Peters, mpeters@eclipsemed.com


'/>"/>
SOURCE Eclipsemed, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs
2. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
3. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
4. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
5. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
6. Applisonix Announces Breakthrough in Ultrasound Technology for Hair Removal - Average Hair Reduction of 38% Following Initial Treatment
7. Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development
8. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
9. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
10. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
11. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... SAN MATEO, Calif. , March 27, 2017 ... has been acquired by Ethicon, a division of ... Reflux Management System for the treatment of gastro-esophageal ... on magnetic sphincter augmentation (MSA) technology and the ... European medical centers. Torax Medical was ...
(Date:3/27/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... AGI-134, an immunotherapy for the treatment of multiple cancers, obtained ... featured at the upcoming American Association for Cancer Research ... to be held on April 1-5, 2017. ... An abstract titled ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 2017 , ... Alert Sentry Group LLC., a leader in the Personal Emergency ... iSAFE and the iSAFE Plus. These iSAFE products are the most affordable and most ... and iSAFE Plus offer direct GPS Location and two-way calling with the push of ...
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. ... will speak to the press on behalf of over 200 doctors, scientists, and scientific ... commission. , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, ...
(Date:3/28/2017)... VA (PRWEB) , ... March 28, 2017 , ... The ... Still, MHA, FRBMA, has begun to serve as its new executive director. Mr. Still ... the Executive Search Committee. , “Bob, as he is known to our members, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning ... will begin serving as new board chair for Orange County health care system ... the remainder of soon-to-be former chair Mark Refowitz’s term, which runs through June ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of two biometric time and attendance tracking products: the new NCheck Cloud Bio ... Cloud Bio Attendance uses biometric face recognition to enable users to check in ...
Breaking Medicine News(10 mins):